[1] |
Grän, F.; Kerstan, A.; Serfling, E.; Goebeler, M.; Muhammad, K. Current developments in the immunology of psoriasis. Yale J. Biol. Med. 2020, 93, 97–110.
|
[2] |
Raharja, A.; Mahil, S.; Barker, J. Psoriasis: a brief overview. Clin. Med. 2021, 21, 170–173.
|
[3] |
van de Kerkhof, P.C.M. From empirical to pathogenesis-based treatments for psoriasis. J. Investig. Dermatol. 2022, 142, 1778–1785.
|
[4] |
Zhou, Q.; Yang, L.J.; Li, T.; Wang, K.W.; Huang, X.B.; Shi, J.F.; Wang, Y. Mechanisms and inhibitors of ferroptosis in psoriasis. Front. Mol. Biosci. 2022, 9, 1019447.
|
[5] |
Wu, M.N.; Zhou, D.M.; Jiang, C.Y.; Chen, W.W.; Chen, J.C.; Zou, Y.M.; Han, T.; Zhou, L.J.M. Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis. Front. Immunol. 2023, 13, 1104462.
|
[6] |
Shi, Y.L. Interpretation of guideline for the diagnosis and treatment of psoriasis in China (2023 edition). J. Tongji Univ. (Med. Sci.). 2023, 44, 631–633.
|
[7] |
Wang, R. Iron-dependent Apoptosis-related Genes Screening and Prediction of Targeted Drugs in Endometrial Cancer Based on Bioinformatics. Jilin Univ. 2024.
|
[8] |
Zhu, Y.N.; Yuan, R.; Zhao, Y.L.; Zhang, H.L.; Cui, X.Q.; Yang, S.Q. Research progress on the regulation of PI3K/Akt/mTOR signaling pathway by cooling and detoxifying herbs in the treatment of psoriasis. Shaanxi J. TCM. 2024, 45, 999–1001.
|
[9] |
Yan, J.G. Correlations among HIF-1α and MMP-9 levels at lesion sites and disease severity in patients with psoriasis vulgaris. Chin. J. Ment. Health. 2023, 35, 162–164.
|
[10] |
Yang, C.G.; Wang, Y.Q.; Li, L.Q.; Xie, S.; Li, J.F.; Wei, J.X.; Chen, N.; Luo, Z.M.; Liu, L.M.; Chen, G.W. The Effect Mechanism of Tiaozhong Huashi Decoction Regulating the ACSL4/LPCAT3/POR Pathway on Esophageal Cell Ferroptosis in GERD Rats. Lishizhen Med. Mater. Med. Res. 2024, 35, 1328–1332.
|
[11] |
Wang, J.Y. ANO6 Inhibits Ferroptosis in Gastric Cancer via the AKT-ACSL4 Pathway. Jilin Univ. 2023.
|
[12] |
Li, Y.D.; Man, X.H.; Yu, L.P.; Zhang, X.Y. The expression and significance of PTEN in the lesionse of psoriasis and non-melanoma tumors. J. Pract. Dermat. 2018, 11, 1–4.
|
[13] |
Li, X.J. Inhibition of HaCaT Cell Proliferation by Let-7a-5p and Detection and Analysis of Its Association with SNPs in Psoriasis. Jilin Univ. 2022.
|
[14] |
Yao, P.P.; Jia, Y.Y.; Kan, X.W.; Chen, J.Q.; Xu, J.L.; Xu, H.C.; Shao, S.Y.; Ni, B.; Tang, J. Identification of ADAM23 as a potential signature for psoriasis using integrative machine-learning and experimental verification. Int. J. Gen. Med. 2023, 16, 6051–6064.
|
[15] |
Yang, Z.L. Protective Role and Mechanism of RACK1 in Hepatic Ischemia-reperfusion Injury. Air Force Med. Univ. 2023.
|
[16] |
Yan, H.M.; Wu, S.T; Wu, Y.Y.; Dong, G.F. Bioinformatics mining of ferroptosis-related biomarkers and construction of diagnostic model in primary Sjögren’s syndrome. J. Pract. Clin. Med. 2023, 27, 12–20.
|
[17] |
Tong, Y.; Zhou, H.Y.; Zhao, P.; Xu, H.D. The mechanism of ferroptosis-related genes in metastatic osteosarcoma. J. Med. Postgraduates. 2021, 34, 457–462.
|
[18] |
Ye, S.Z.; Ling, G.H.; Xiao, M.; Chen, M.L. Discussion on the Traditional Chinese Medicine Treatment of Psoriasis Vulgaris Based on the Regional Characteristics of Sichuan. Bullet. Dermat. 2024, 41, 348–351.
|
[19] |
Duan, X.W. Experience in Syndrome Differentiation and Treatment of Psoriasis. Chin. J. Int. Med. 2015, 35, 1299–1301.
|
[20] |
Li, Z.G.; Jiao, Y.; Liu, L.X.; Lu, H.Q.; Wei, Y.C. Experience of Wei Yachuan in Treating Psoriasis Vulgaris. Chin. J. Basic Med. TCM. 2021, 27, 318–320.
|